Supply chain management
The American Hospital Association (AHA) provides resources on supply chain management, the management of health care supplies manufacturing, distribution, delivery, utilization, and replacement.
Today on a call hosted by the Department of Health and Humans Services, Heather Knight, Baxter executive vice president and group president of medical products and therapies, announced that Baxter will be changing allocation for some IV solution supplies from 40% to 60% effective tomorrow, Oct. 9.
AHA President and CEO Rick Pollack Oct. 7 sent a letter to President Biden urging the Administration to take immediate actions to increase the supply of IV solutions for hospitals and other health care providers that are struggling with shortages following the closure of a Baxter manufacturing…
AHA letter to President Biden urging the Administration to take action to address IV solution supply shortage as a result of hurricane Helene.
AHA President and CEO Rick Pollack today sent a letter to President Biden urging the Administration to take immediate actions to increase the supply of IV solutions for hospitals and other health care providers that are struggling with shortages following the closure of a Baxter manufacturing plant…
The AHA is continuing efforts on multiple fronts to provide updates on the supply chain issues resulting from the closure of a Baxter manufacturing plant in North Carolina because of damage from Hurricane Helene.
The Department of Health and Human Services Sept. 30 released a statement on the dockworker strike at ports along the East and Gulf coasts, saying that immediate impacts to medicines, medical devices and other goods should be limited.
The Administration for Strategic Preparedness and Response July 16 announced it will work with the Department of Commerce on an assessment of the active pharmaceutical industrial base to better understand the pharmaceutical supply chain and how it has changed since the COVID-19 pandemic.
The AHA sent a letter June 28 to the U.S. Trade Representative responding to a proposed increase in Section 301 tariffs for goods produced in China, which would include health care products.
June 28, 2024 The Honorable Katherine TaiU.S. Trade Representative600 17th Street NWWashington, DC 20508Re: Proposed change to Section 301 tariffs for goods made in China - 90183100Dear Ambassador Tai:
ASHP tracked a record 323 active drug shortages during the first quarter of 2024, surpassing the previous record of 320 shortages in 2014.